New

Touch BR (1 vial)

In Stock

$ 40

Decreases melanin synthesis

The Korean mesotherapy skin booster Touch BR prevents the synthesis of melanin pigmentation in the skin which decreases the skin pigmentation, ages spots and freckles. This contributes to illuminate, depigmentate and has a whitening effect on the skin. 

Touch BR is:

  • Whitening
  • Illuminating
  • Depigmentation
  • Luminating
  • Whitening
  • Long lasting
  • Effective

Using Touch BR is recommended when you want to treat age spots, skin issues due to dyschromias of hormonal origin (pregnancy, menopause), sun damage or aged skin. 

To achieve the best results it is highly recommended to repeat the Touch BR procedure at least 6 times. A Touch BR treatment can also be combined with Touch UP for a better whitening effect. 

 

Touch BR Ingredients:

  • 3 Biomimetic peptides: Oligopeptide-50, Oligopeptide-34, Oligopeptide-51 (prevents melanin synthesis)
  • Whitening boosting complex XT80 (patented technology consisting of 34 Amino acids and vitamin complexes)
  • Niacinamide (skin lightening agent)
  • Vitamin C (prevents melanin synthesis & acts as antioxidant)

Inject Touch BR into the dermis using 32G needle, 4 mm. It can also can be used with MTS and derma roller.

Touch BR Before After: 

 

Touch BR Product Specifications: 

Volume   : 2ml x 1 Vial
Storage instruction   : Keep sealed and store in cool (2°- 8°C), dry and dark place (away from direct sunlight).
Country of Manufacturing   : South Korea
Manufacturer   : Dexlevo
Expiration : 24 months from manufacturing date 

Video: 

 

Reviews for Touch BR (1 vial)

Add a review

Write a message

Please rate on a scale of 5

Related Products

Dermaheal HSR
Dermaheal HSR
Meso Therapy
$119
Dermaheal Dark circle solution
$103
Dermaheal eyebag solution
$103
Dermaheal SR
Dermaheal SR
Meso Therapy
$112
Dermaheal SB
Dermaheal SB
Meso Therapy
$113
Selatox10
Selatox10
Meso Therapy
$91
Tox & Eye HP Cell Regation
$159
Miracle H (1 vial)
Miracle H (1 vial)
Meso Therapy
$70

20% Discount!
Subscribe to our newsletter